During the past decade, Stronach Regional Health Centre at Southlake conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 16 clinical trials were completed, i.e. on average, 106.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 10 clinical trials were completed. i.e. 1000% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stronach Regional Health Centre at Southlake" #1 sponsor was "Canadian Cancer Trials Group" with 10 trials, followed by "NCIC Clinical Trials Group" with 5 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored and "National Cancer Institute (NCI)" with 2 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stronach Regional Health Centre at Southlake" #1 collaborator was "National Cancer Institute (NCI)" with 8 trials as a collaborator, "Eastern Cooperative Oncology Group" with 4 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 3 trials as a collaborator, "North Central Cancer Treatment Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 3 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 34 trials.

According to Clinical.Site data, the most researched conditions in "Stronach Regional Health Centre at Southlake" are "Breast Cancer" (10 trials), "Colorectal Cancer" (2 trials), "Invasive Breast Carcinoma" (2 trials), "Anxiety Disorder" (1 trials) and "Bladder Cancer" (1 trials). Many other conditions were trialed in "Stronach Regional Health Centre at Southlake" in a lesser frequency.

Most popular intervention types in "Stronach Regional Health Centre at Southlake" are "Drug" (23 trials), "Other" (12 trials), "Radiation" (6 trials), "Biological" (4 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Laboratory Biomarker Analysis" (4 trials), "Quality-of-Life Assessment" (4 trials), "placebo" (4 trials) and "Paclitaxel" (3 trials). Other intervention names were less common.

The vast majority of trials in "Stronach Regional Health Centre at Southlake" are 22 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Stronach Regional Health Centre at Southlake". undefined are not yet recruiting, 2 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Stronach Regional Health Centre at Southlake, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Stronach Regional Health Centre at Southlake, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".